• Blog
  • In Vitro Diagnostic Testing Market Report

    In Vitro Diagnostic Testing Market Report

    In Vitro Diagnostic Testing Market Report
    Report code - SRHL118 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Opportunities & Gaps in the In Vitro Diagnostic Testing Market:  By Product (Inst See more...

    Impact of COVID-19 on In Vitro Diagnostic Testing Market

    Covid-19 has impacted the market dynamics, competition, and global...

    See more...

    Impact of COVID-19 on In Vitro Diagnostic Testing Market

    Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.

    Note: The summary below might not have included insights on covid impact since we have large number of reports.

    This report, from Stratview Research, studies the clinical diagnostics market over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.

    The Burning Questions This Report Will Answer:

    1. How cost effective are in vitro diagnostics methods compared to POC testing?
    2. Is there a scope for newer technology player to enter the market (such as finger print technology, cloud based, etc)?
    3. Can the issue of test result reproducibility be standardized in the IVD segment?
    4. Which type of tests are in demand? Is it dependent on lifestyle or disease prevalence?
    5. Are these tests getting healthcare coverage (insurance)?
    6. How are the major players in the market? What role do they play in influencing the market demands?

    The Global Clinical Diagnostics Market – IVD: Highlights

    In IVD market oncology is one of the most sought-after segments by the manufacturers. Non-invasive cancer testing is expected to be a hot market in 2019.  Qiagen, one of the global MNC, has been pioneering the use of liquid biopsy-based companion diagnostics as a less-invasive option to complement surgical biopsies for genomic profiling of cancers. In the infectious diseases segment, most of the currently available tests detect a single pathogen, or an antibiotic resistance gene. However, if a patient presents with general symptoms of a respiratory infection, or with symptoms of a gastrointestinal infection or some other type of infection, there are several different pathogens that may have caused the infection. However, syndromic testing is soon becoming a reality where multiple pathogens can be detected, increasing the chances of detection, bringing down the cost of testing and directly impacting the DALY of patients.

    Over the years, the market has been driven by big names of IVD such as Roche Diagnostics Limited (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott Laboratories (US), and Thermo Fisher Scientific (US) who have been bending the rules of the game. However, in recent years, there are several market disruptors who are openly challenging the monopoly of these players and determined to bring down the cost of care and introduce user friendly and cost effective services and IVD equipment in the market.

    Research Methodology

    Our reports offer high-quality insights and are the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. About 10 detailed primary interviews with the market players across the value chain in all four regions and industry experts have been executed to obtain both the qualitative and quantitative insights.

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:

    • Market structure: Overview, industry life cycle analysis, supply chain analysis
    • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
    • Market trend and forecast analysis
    • Market segment trend and forecast
    • Competitive landscape and dynamics: Market share, Product portfolio, New launches, etc.
    • Attractive market segments and associated growth opportunities
    • Emerging trends
    • Strategic growth opportunities for the existing and new players
    • Key success factors 
    • Future outlook

    The global clinical diagnostics market (IVD) is segmented into the following categories: 

    By Product

    • Instruments, Reagent 

    By Technology

    • Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology, Urinalysis, Microbiology 

    By Application

    • Diabetes, Infectious diseases, Oncology, Cardiology, Nephrology, Other Diseases 

    By Type of Demand for Sample

    • Urine, Hair, Oral 

    By Testing Facility

    • Hospital Laboratories, Independent Clinical Laboratories, Drug Rehabilitation Centers, Others

    By Region

    • North America (Country Analysis: the USA, Canada)
    • Western Europe (Country Analysis: Germany, France, the UK)
    • Asia-Pacific (Country Analysis: China, Japan, India, and Rest of Asia-Pacific)
    • Latin America (Country Analysis: Brazil, Argentina, Mexico, and Others)
    • Rest of the World (Sub-Region Analysis: The Middle East, Africa, Rest of Europe and Others) 

    Report Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our first-time clients:

    Company Profiling

    • SWOT analysis of key players (up to 3 players)
    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].